WHO. 2011c. Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis: 2011 Update. http://www.who.int/tb/challenges/mdr/programmatic_guidelines_for_mdrtb/en/index.html (accessed December 5, 2011).

World Economic Forum. 2008. Tackling Tuberculosis: The Business Response. http://members.weforum.org/pdf/GHI/TB.pdf (accessed April 19, 2012).

Wright, A., M. Zignol, A. Van Deun, D. Falzon, S. R. Gerdes, K. Feldman, S. Hoffner, F. Drobniewski, L. Barrera, D. van Soolingen, F. Boulabhal, C. N. Paramasivan, K. M. Kam, S. Mitarai, P. Nunn, M. Raviglione, and Global Project on Anti-Tuberculosis Drug Resistance Surveillance. 2009. Epidemiology of antituberculosis drug resistance 2002-07: An updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance. Lancet 373(9678):1861-1873.

Yadav, P. 2011. MDR-TB: Challenges in Drug Supply Chain Logistics. Speaker presentation at the Institute of Medicine Workshop on Facing the Reality of Drug-Resistant Tuberculosis in India: Challenges and Potential Solutions, April 19, New Delhi, India.

Zignol, M., W. van Gemert, D. Falzon, C. Sismanidis, P. Glaziou, K. Floyd, and M. Raviglione. 2012. Surveillance of anti-tuberculosis drug resistance in the world: An updated analysis, 2007-2010. Bulletin World Health Organization 90:111D-119D.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement